for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Qiagen NV

QGEN.N

Latest Trade

27.54USD

Change

0.04(+0.15%)

Volume

431,436

Today's Range

27.20

 - 

27.70

52 Week Range

25.06

 - 

41.52

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
27.50
Open
27.30
Volume
431,436
3M AVG Volume
27.13
Today's High
27.70
Today's Low
27.20
52 Week High
41.52
52 Week Low
25.06
Shares Out (MIL)
226.47
Market Cap (MIL)
6,287.79
Forward P/E
20.38
Dividend (Yield %)
--

Next Event

Q3 2019 Qiagen NV Earnings Release

Latest Developments

More

Qiagen Says Shifting Global Operations Organization To Regional Manufacturing Structure

Qiagen Sees Q3 Prelim Total Net Sales Growth Of About 3%

Qiagen Says Peer Schatz To Step Down As CEO

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Qiagen NV

QIAGEN N.V. (QIAGEN) is a holding company. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Industry

Biotechnology & Drugs

Contact Info

Hulsterweg 82

+31.77.3556600

https://www.qiagen.com/

Executive Leadership

Hakan Bjorklund

Independent Chairman of the Supervisory Board

Thierry Bernard

Interim Chief Executive Officer, Member of the Executive Committee

Roland Sackers

Managing Director, Chief Financial Officer, Member of the Executive Committee

Barthold Piening

Senior Vice President, Head of Global Operations, Member of the Executive Committee

Annette Koch

Senior Vice President and Chief Human Resources Officer, Member of the Executive Committee

Key Stats

3.09 mean rating - 11 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

1.3K

2017

1.4K

2018

1.5K

2019(E)

1.5K
EPS (USD)

2016

1.110

2017

1.270

2018

1.340

2019(E)

1.337
Price To Earnings (TTM)
32.53
Price To Sales (TTM)
4.16
Price To Book (MRQ)
2.34
Price To Cash Flow (TTM)
15.12
Total Debt To Equity (MRQ)
67.02
LT Debt To Equity (MRQ)
53.58
Return on Investment (TTM)
4.42
Return on Equity (TTM)
3.66

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up